Conference
CCTG PR21: A randomized phase II study of [177lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancer and PSMA-positive disease (NCT04663997)
Authors
Chi KN; Saad F; Parulekar WR; Emmenegger U; Hotte SJ; Pouliot F; Bauman G; Zukotynski KA; Peacock S; Wyatt AW
Volume
40
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2022
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
ELECTR NETWORK
Conference start date
June 3, 2022
Conference end date
June 7, 2022
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X